Landenberg, PA, United States of America

Krishnaswamy Yeleswaram

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in JAK Inhibitor Formulations. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Incyte Holdings Comoration. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishnaswamy Yeleswaram. Retrieved from https://idiyas.com/inventor/krishnaswamy-yeleswaram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 178(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Topical Formulation
JAK Inhibitor
Sustained Release
Dosing Regimen
FGFR Inhibitor
Cancer Treatment
Gastrointestinal Disease
Ruxolitinib
PI3K Disorders
JAK1 Pathway
Dosage Forms
Pharmaceuticals
23 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Krishnaswamy Yeleswaram

Introduction: Krishnaswamy Yeleswaram is a prominent inventor based in Landenberg, PA, USA, with an impressive portfolio of 20 patents to his name. His work primarily revolves around pharmaceuticals, focusing on innovative formulations and treatment methods for various medical disorders.

Latest Patents: Among his notable inventions, Krishnaswamy's latest patents include a topical formulation for a JAK inhibitor. This invention involves pharmaceutical formulations designed for topical skin application, comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile or its pharmaceutically acceptable salts, which aims to treat skin disorders. Another significant contribution is related to the dosing regimen for the treatment of PI3Kδ related disorders, providing methods that employ pyrazolopyrimidine derivatives to effectively address these medical challenges.

Career Highlights: Throughout his career, Krishnaswamy has made substantial contributions to the pharmaceutical field, particularly in the companies he has worked for, including Incyte Corporation and Incyte Holdings Corporation. His expertise in drug development and formulation has positioned him as a valuable asset within the industry.

Collaborations: Krishnaswamy Yeleswaram has collaborated with esteemed colleagues such as Bhavnish Parikh and Yong Ni. These partnerships have likely facilitated innovative ideas and advancements in pharmaceutical research and development, enhancing the quality and effectiveness of their work.

Conclusion: With his extensive experience and a strong record of patent contributions, Krishnaswamy Yeleswaram continues to influence the pharmaceutical industry through his inventive methods and formulations. His work not only addresses specific medical issues but also showcases the vital role of innovation in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…